2022 annual financial data

Olema Pharmaceuticals 2022 Net margin

Direct answer

Net margin was Not calculable.

Operating income was -106,988,000 USD and net income was -102,586,000 USD.
Operating cash flow was -82,065,000 USD.

Get free Olema Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-106,988,000 USD
Net income
-102,586,000 USD
Operating cash flow
-82,065,000 USD